These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8748676)

  • 21. Inhibition of rat brain histamine-N-methyltransferase by 9-amino-1,2,3,4-tetrahydroacridine (THA).
    Cumming P; Reiner PB; Vincent SR
    Biochem Pharmacol; 1990 Sep; 40(6):1345-50. PubMed ID: 2403387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
    El-Malah A; Gedawy EM; Kassab AE; Salam RM
    Arch Pharm (Weinheim); 2014 Feb; 347(2):96-103. PubMed ID: 24343873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tacrine treatment of Alzheimer's disease: many expectations, few certainties.
    Malaguarnera M; Pistone G; Vinci M; Motta M; di Fazio I; Rampello L
    Neuropsychobiology; 1998 Nov; 38(4):226-31. PubMed ID: 9813462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of GSK-3 overactivation on neurofilament phosphorylation.
    Chen J; Zhou J; Feng Y; Wang J
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(4):375-7, 403. PubMed ID: 16196280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrine in the treatment of Alzheimer's disease. A clinical update and recent pharmacologic studies.
    Summers WK; Tachiki KH; Kling A
    Eur Neurol; 1989; 29 Suppl 3():28-32. PubMed ID: 2693104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple effects of tetrahydroaminoacridine on the cholinergic system: biochemical and behavioural aspects.
    Adem A; Mohammed AK; Winblad B
    J Neural Transm Park Dis Dement Sect; 1990; 2(2):113-28. PubMed ID: 2222779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term treatment with tacrine (THA) in Alzheimer's disease--evaluation of neuropsychological data.
    Amberla K; Nordberg A; Viitanen M; Winblad B
    Acta Neurol Scand Suppl; 1993; 149():55-7. PubMed ID: 8128841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacrines as Therapeutic Agents for Alzheimer's Disease. IV. The Tacripyrines and Related Annulated Tacrines.
    Bartolini M; Marco-Contelles J
    Chem Rec; 2019 May; 19(5):927-937. PubMed ID: 30489012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 9-Amino-1,2,3,4-tetrahydroacridine (THA) blocks agonist-induced potassium conductance in rat hippocampal neurones.
    Halliwell JV; Grove EA
    Eur J Pharmacol; 1989 Apr; 163(2-3):369-72. PubMed ID: 2721578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel anticholinesterase THB013: biochemical and behavioural studies.
    Adem A; Mohammed AH; Winblad B; Henriksson BE
    J Neural Transm Park Dis Dement Sect; 1994; 8(1-2):139-48. PubMed ID: 7893376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bis(7)-tacrine, a novel dimeric AChE inhibitor, is a potent GABA(A) receptor antagonist.
    Li CY; Wang H; Xue H; Carlier PR; Hui KM; Pang YP; Li ZW; Han YF
    Neuroreport; 1999 Mar; 10(4):795-800. PubMed ID: 10208550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 9-Amino-1,2,3,4-tetrahydroacridine is a potent inhibitor of histamine N-methyltransferase.
    Nishibori M; Oishi R; Itoh Y; Saeki K
    Jpn J Pharmacol; 1991 Apr; 55(4):539-46. PubMed ID: 1886293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains.
    Nordberg A; Nilsson-Håkansson L; Adem A; Lai Z; Winblad B
    Prog Clin Biol Res; 1989; 317():1169-78. PubMed ID: 2557636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of tacrine and velnacrine with neocortical synaptosomal membranes: relevance to Alzheimer's disease.
    Butterfield DA; Hensley K; Hall N; Umhauer S; Carney J
    Neurochem Res; 1993 Sep; 18(9):989-94. PubMed ID: 8232727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
    Li SY; Wang XB; Xie SS; Jiang N; Wang KD; Yao HQ; Sun HB; Kong LY
    Eur J Med Chem; 2013 Nov; 69():632-46. PubMed ID: 24095756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrine therapy for the dementia of Alzheimer's disease.
    Manning FC
    Am Fam Physician; 1994 Sep; 50(4):819-26. PubMed ID: 8079912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Shao D; Zou C; Luo C; Tang X; Li Y
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
    Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrine: first drug approved for Alzheimer's disease.
    Crismon ML
    Ann Pharmacother; 1994 Jun; 28(6):744-51. PubMed ID: 7919566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphological alterations in erythrocyte membranes induced by 9-amino-1,2,3,4-tetrahydroacridine and 9-aminoacridine.
    Palmieri DA; Jacob RJ; Butterfield DA
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1351-5. PubMed ID: 2783139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.